Personalis to Announce Fourth Quarter and Full Year 2023 Financial Results
Personalis, Inc. (PSNL) will release its Q4 and full year 2023 financial results on February 28, 2024. A conference call and webcast will follow to discuss the results and recent highlights.
02/14/2024 - 04:01 PM
FREMONT, Calif. --(BUSINESS WIRE)--
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that it will release its fourth quarter and full year 2023 financial results on Wednesday, February 28, 2024. In conjunction with the release, Personalis will host a conference call and webcast that day at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to discuss its financial results and recent highlights.
Interested parties may access the call by dialing 877-451-6152 for domestic callers or 201-389-0879 for international callers. The webinar of the call may be accessed by visiting the Events section of the company's website at investors.personalis.com. A replay of the webinar will be available shortly after the conclusion of the call and will be archived on the company's website.
About Personalis, Inc.
At Personalis, we are transforming the active management of cancer through breakthrough personalized testing. We aim to drive a new paradigm for cancer management, guiding care from biopsy through the life of the patient. Our highly sensitive assays combine tumor-and-normal profiling with proprietary algorithms to deliver advanced insights even as cancer evolves over time. Our products are designed to detect minimal residual disease (MRD) and recurrence at the earliest time points, enable the selection of targeted therapies based on ultra-comprehensive genomic profiling, and enhance biomarker strategy for drug development. Personalis is based in Fremont, California . To learn more, visit www.personalis.com and connect with us on LinkedIn and X (Twitter) .
View source version on businesswire.com: https://www.businesswire.com/news/home/20240214090295/en/
Investors:
investors@personalis.com
Media:
pr@personalis.com
Source: Personalis, Inc.
When will Personalis, Inc. release its Q4 and full year 2023 financial results?
Personalis, Inc. will release its Q4 and full year 2023 financial results on February 28, 2024.
What time will the conference call and webcast take place?
The conference call and webcast will take place at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time on February 28, 2024.
How can interested parties access the conference call?
Interested parties can access the call by dialing 877-451-6152 for domestic callers or 201-389-0879 for international callers.
Where can the webinar of the call be accessed?
The webinar of the call may be accessed by visiting the Events section of the company's website at investors.personalis.com.
Will there be a replay of the webinar available?
Yes, a replay of the webinar will be available shortly after the conclusion of the call and will be archived on the company's website.
PSNL Rankings
#4996 Ranked by Stock Gains
PSNL Stock Data
Industry
Medical Laboratories
Sector
Health Care and Social Assistance
Tags
Biotechnology, Health Technology, Health Care and Social Assistance, Medical Laboratories
Country
US
City
Menlo Park
About PSNL
personalis is a genome-scale diagnostics company with a mission to pioneer genome guided medicine. our priority is to obtain the most accurate genetic data from each sample, and then to draw the most reliable medically-focused conclusions from these. our tests are based on whole human genome and exome sequencing, conducted in our state-of-the art laboratory. we analyze results utilizing proprietary databases, advanced human reference sequences, and sophisticated algorithms. personalis genome services provides academic, pharmaceutical, and biotech researchers an accurate and comprehensive end-to-end human genome sequencing and analysis solution. our services support researchers engaging in large case-control and family-based genome studies of complex or mendelian diseases and traits, pharmacogenomics, and cancer.
